Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2002
03/19/2002US6358686 An allele-specific oligonucleotides that hybridizes to polymorphic sites for analyzing nucleic acids to test for phenotypic differences; for genetic engineering of crops
03/19/2002US6358685 Nucleic acid displacer compositions and cells comprising same
03/19/2002US6358684 Hybridizing nucleic acid sequence with fluorescently labeled oligonucleotide primer in presence of deoxynucleoside triphosphates, dideoxynucleoside triphosphate and dna polymerase, fluorescently measuring mixture formed to sequence
03/19/2002US6358683 Blood-based assays for breast cancer
03/19/2002US6358682 Method and kit for the prognostication of breast cancer
03/19/2002US6358681 Contacting brain tissue with a fluorescent dye capable of intercalating selectively into nucleic acids, and detecting any fluorescence indicative of senile plaques, neurofibrillary tangles and neuropil threads
03/19/2002US6358680 Detection of wheat and barley fungal pathogens using the polymerase chain reaction
03/19/2002US6358679 Methods for external controls for nucleic acid amplification
03/19/2002US6358613 Silicon substrate with layers of vinyl or alkyl groups bonded to silicon surface
03/19/2002US6357307 System and method of flow cytometry and sample handling
03/19/2002US6357163 Use of nucleic acid analogues in diagnostics and analytical procedures
03/15/2002CA2357074A1 Novel bcl-2 related proline rich protein (bpr)
03/14/2002WO2002021576A2 Organic nanoelectric conductors
03/14/2002WO2002021418A2 Method and system for identifying commercially distributed organisms
03/14/2002WO2002021140A1 Nucleic acid sequences and proteins involved in cellular senescence
03/14/2002WO2002021132A2 Cell assays
03/14/2002WO2002021129A1 Method of monitoring the effect of cathepsin s inhibitors
03/14/2002WO2002021126A2 Method for detecting the activity of active ingredients
03/14/2002WO2002021125A2 Drug discover employing calorimetric target triage
03/14/2002WO2002021098A2 A method for identifying polymorphisms
03/14/2002WO2002020852A1 Amplification of hiv-1 sequences for detection of sequences associated with drug-resistance mutations
03/14/2002WO2002020851A1 Haplotypes of the scya24 gene
03/14/2002WO2002020850A2 Novel prkag3 alleles and use of the same as genetic markers for reproductive and meat quality traits
03/14/2002WO2002020849A2 Gene markers useful for detecting skin damage in response to ultraviolet radiation
03/14/2002WO2002020848A2 Gene and sequence variation associated with cancer
03/14/2002WO2002020847A2 Gene and sequence variation associated with lipid disorder
03/14/2002WO2002020846A2 Screening methods to identify compounds that modulate a response of a cell to ultraviolet radiation exposure
03/14/2002WO2002020845A2 Ultra yield amplification reaction
03/14/2002WO2002020844A1 Methods and products related to high throughput genotype analysis
03/14/2002WO2002020843A1 A method for sequencing nucleic acid sequences without chain termination
03/14/2002WO2002020842A1 System, method and apparatus for transgenic and targeted mutagenesis screening
03/14/2002WO2002020841A2 5-hydroxytryptamine receptor gene polymorphisms and response to treatment
03/14/2002WO2002020839A1 Method of determining base sequence
03/14/2002WO2002020838A2 Method and system for detecting nucleic acids
03/14/2002WO2002020837A2 Method of nucleic acid typing or sequencing
03/14/2002WO2002020836A2 Method of sequencing dna
03/14/2002WO2002020835A2 Genetic study
03/14/2002WO2002020833A2 Method for the specific determination of dna -sequences by means of parallel amplification
03/14/2002WO2002020832A1 Microsensors and method for detecting target analytes
03/14/2002WO2002020831A2 Method for measurement of the activity of no-synthase
03/14/2002WO2002020830A2 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds
03/14/2002WO2002020829A1 Culture medium and method for identifying gram-negative microorganisms
03/14/2002WO2002020827A1 System and method for tracking and controlling infections
03/14/2002WO2002020826A2 An electronic database of enzyme substrate and enzyme inhibitor structures
03/14/2002WO2002020825A1 Method and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof
03/14/2002WO2002020824A2 Process for estimating random error in chemical and biological assays
03/14/2002WO2002020822A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
03/14/2002WO2002020805A2 Regulation of human carboxypeptidase-like enzyme
03/14/2002WO2002020791A1 Plant resistance gene
03/14/2002WO2002020788A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002WO2002020787A1 Mutated aqp, method for detecting cancer using the same, dna chip having oligonucleotides of said mutated aqp sequence
03/14/2002WO2002020770A1 Method of screening antitumor agent by using interaction between arf protein and hk33 protein
03/14/2002WO2002020769A1 Human and mouse targeting peptides identified by phage display
03/14/2002WO2002020768A2 Caveolin peptides and their use as therapeutics
03/14/2002WO2002020767A2 G-csf analog compositions and methods
03/14/2002WO2002020766A2 G-csf analog compositions and methods
03/14/2002WO2002020764A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002WO2002020763A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002WO2002020762A2 Tnf receptor-like molecules and uses thereof
03/14/2002WO2002020757A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002WO2002020754A2 Molecules for diagnostics and therapeutics
03/14/2002WO2002020749A2 Chimeric reporter system for cell surface receptor-ligand binding
03/14/2002WO2002020747A2 Regulation of human tyrosine phosphatase-like enzyme
03/14/2002WO2002020736A2 Proteases
03/14/2002WO2002020735A2 Enzymes having high temperature polymerase activity and methods of use thereof
03/14/2002WO2002020728A2 High growth methanotrophic bacterial strain methylomonas 16a
03/14/2002WO2002020724A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
03/14/2002WO2002020723A2 Compositions and methods for targeting peptides in humans in vivo
03/14/2002WO2002020722A2 Methods and compositions for in vitro targeting
03/14/2002WO2002020718A2 Osteoclast-associated receptor
03/14/2002WO2002020571A2 Attenuated hiv strains and use thereof
03/14/2002WO2002020570A2 Mitochondrial membrane permeabilization bv hiv-1 vpr and methods of screening
03/14/2002WO2002020563A2 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN
03/14/2002WO2002020562A2 Family member of inhibitor of apoptosis proteins
03/14/2002WO2002020560A1 Novel human cancer/testis antigen and gene thereof
03/14/2002WO2002020556A2 Haplotypes of the gpr68 gene
03/14/2002WO2002020514A1 Multivalent neuraminidase inhibitor conjugates
03/14/2002WO2002020435A2 Generation of combinatorial libraries and assessment thereof by deconvolution
03/14/2002WO2002020416A2 Polyhydroxyalkanoate levels as an indicator of bioreactor health
03/14/2002WO2002020179A2 Modified carbon, silicon and germanium surfaces
03/14/2002WO2002020056A2 Methods and compositions for producing a neurosalutary effect in a subject
03/14/2002WO2002020036A1 Medicament comprising a dna sequence, which codes for the rna-binding koc protein, and comprising a koc protein or a dna sequence of the koc promoter
03/14/2002WO2002020003A2 Use of carp inhibitors for the treatment of heart diseases
03/14/2002WO2002019822A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
03/14/2002WO2002019812A2 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor
03/14/2002WO2001090189A3 G-protein coupled receptor org3.
03/14/2002WO2001090124A3 Haplotypes of the gpr31 gene
03/14/2002WO2001087921A3 Gene responsible for stargardt-like dominant macular dystrophy
03/14/2002WO2001083499A3 Haplotypes of the il8 gene
03/14/2002WO2001081581A3 Compositions and methods for the therapy and diagnosis of acne vulgaris
03/14/2002WO2001080718A3 Methods and compositions for the diagnosis of schizophrenia
03/14/2002WO2001080712A3 Method of determining a risk of hyperglycemic patients of developing a cardiovascular disease
03/14/2002WO2001079235A3 Haplotypes of the dnal4 gene
03/14/2002WO2001079232A3 Haplotypes of the mpl gene
03/14/2002WO2001079221A3 Haplotypes of the il8rb gene
03/14/2002WO2001079220A3 Haplotypes of the hrh2 gene
03/14/2002WO2001079218A3 Haplotypes of the calm1 gene
03/14/2002WO2001078575A3 Ext2 as a predictive marker for osteoporosis
03/14/2002WO2001077363A3 Haplotypes of the impdh2 gene
03/14/2002WO2001077127A3 Haplotypes of the apoc4 gene
1 ... 2331 2332 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 ... 3003